Overview
Algama is a Paris-based food technology company pioneering the use of microalgae as a sustainable food ingredient source. Founded in 2013 by Alvyn Severien and Benjamin Gonzalez, the company develops microalgae-derived ingredients that replace conventional animal proteins — eggs, dairy — in food formulations, providing complete nutrition with a fraction of the environmental footprint. Algama’s signature ingredient is a spirulina-based egg replacer that functions identically to whole eggs in cooking and baking applications, enabling food manufacturers to reformulate products without changing consumer experience.
The commercial logic of microalgae as food is compelling: spirulina and chlorella grow 25x faster than terrestrial crops, require no arable land, produce 10x more protein per hectare than soy, and can be cultivated on non-potable water. These sustainability metrics make microalgae central to France 2030’s “third agricultural revolution” — the transformation of French food production toward biological efficiency rather than chemical intensification. As France grapples with agricultural land pressure and the imperative to reduce livestock’s environmental impact, microalgae represent one of the clearest paths to decoupling food protein production from land use.
France 2030 Funding & Projects
Algama participates in France 2030’s food and agriculture axis, which President Macron specifically included in the ten strategic objectives announced in October 2021. The alternative proteins segment — encompassing plant-based, fermentation-derived, and cell-cultured proteins alongside microalgae — receives France 2030 co-funding through Bpifrance’s deeptech and agrifood programs. Algama has competed in Bpifrance innovation competitions and benefited from ADEME’s sustainable food funding programs, which target the carbon footprint reduction of French food production.
The company has also partnered with INRAE (France’s National Research Institute for Agriculture, Food and Environment) — a France 2030-supported research institution — for strain development and fermentation optimization. Algama’s positioning within the France 2030 ecosystem gives it access to food industry partnership networks facilitated by Bpifrance’s sectoral programs, connecting startups with major food companies including Bonduelle, Danone, and Avril Group that are themselves part of France 2030’s food sovereignty programs.
Strategic Position
Algama operates in the alternative protein ingredients market — projected to reach $17 billion globally by 2030 — alongside competitors including Corbion (Netherlands, algae DHA oils), Allmicroalgae (Portugal), and emerging US companies backed by major food company venture arms. The company’s differentiation lies not in producing microalgae biomass (commoditizing rapidly) but in developing specific functional ingredient applications — the value-added layer above raw biomass production.
The egg replacer market is particularly strategic: egg price volatility (as demonstrated by avian flu outbreaks in 2022–2023 causing 400% egg price spikes) creates structural demand for reliable egg alternatives from food manufacturers. Algama’s spirulina-based egg replacer addresses this demand with a clean-label, allergen-free solution — attributes that command premium pricing versus conventional egg alternatives.
Key Technology & Innovation
Algama’s core IP centers on its proprietary microalgae strain library and fermentation optimization processes for specific ingredient applications. The company has developed techniques for extracting and purifying specific microalgae protein fractions that deliver defined functional properties — emulsification, foaming, gelling — rather than simply producing whole-biomass flour. This functional specificity enables precise formulation for food manufacturer applications.
The company has filed patents covering its extraction and purification processes, and its formulations for specific food applications including egg replacement, dairy alternative enhancement, and nutritional fortification. The IP creates a barrier that pure microalgae biomass producers cannot easily penetrate — the move from commodity biomass to functional ingredients requires food science and application development capabilities that pure biotech companies lack.
Leadership
Alvyn Severien co-founded Algama with a background combining food engineering and sustainability science — a deliberate combination for a company selling to food manufacturers who evaluate ingredients on both technical function and environmental credibility. The founding team’s food industry relationships have been critical to securing pilot partnerships with major food companies for ingredient validation.
Competitive Landscape
Algama competes with Corbion’s Terravia ingredients (acquired from Solazyme), Allmicroalgae, and with the broader plant protein ingredient market (Roquette, ADM, Ingredion). The competitive dynamic is two-tiered: established food ingredient companies are entering microalgae from a strong commercial position, while dedicated startups like Algama compete on technical innovation and first-mover customer relationships. France 2030 support provides Algama with runway to establish customer references before larger ingredient companies compete directly in the same application segments.
Investor Perspective
Algama is an early-stage company in a sector with strong long-term fundamentals but uncertain near-term scaling economics. Microalgae production costs remain higher than conventional plant protein alternatives, requiring either technology cost reduction through process intensification or market conditions (carbon pricing, protein demand shocks) that close the gap. France 2030 support extends Algama’s runway while the cost curve evolves.
For impact investors and food tech specialists, Algama represents an authentic sustainability bet: the technology works, the market need is real, and French policy support is active. The commercialization timeline to significant revenue is measured in years rather than quarters, appropriate for early-stage food ingredient companies building customer qualification pipelines.